Search results
Results from the WOW.Com Content Network
Romosozumab, sold under the brand name Evenity (/ ɪ ˈ v ɛ n ɪ t i / ih-VENN-ih-tee or with the pin-pen merger, / ɪ ˈ v ɪ n ɪ t i / ih-VINN-ih-tee), is a medication used to treat osteoporosis. [7] [8] It has been found to decrease the risk of fractures of the spine. [7] Common side effects include headache, joint pain, and injection site ...
How can you tell if they’re safe past their expiration dates? Here, doctors explain how long most vitamins last and any risks associated with taking expired vitamins.
ExtenZe is an herbal nutritional supplement claiming to promote "natural male enhancement", a euphemism for penis enlargement. [1] ExtenZe paid $6 million to settle a class-action false advertising lawsuit in 2010.
In December 2024, the CHMP adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Stoboclo, intended for the treatment of osteoporosis in women who have been through menopause, bone loss linked to hormone ablation in men at increased risk of fractures and bone loss associated with long-term ...
4. Are some women more at risk for osteoporosis? Yes. Your risk for osteoporosis is higher if you: Are past menopause. After menopause, your ovaries make very little of the hormone estrogen.
Osteoporosis impacts almost 20% of women and 5% of men ages 50 and up, according to the Centers for Disease Control and Prevention, making it a concern for many. Now, a study suggests that working ...
They are used for the treatment of osteoporosis and other bone disorders that cause bone fragility and diseases where bone resorption is excessive. Osteoporosis is common in post-menopausal women and patients in corticosteroid treatment where biphosphonates have been proven a valuable treatment and also used successfully against Paget's disease ...
Long-term treatment with bisphosphonates produces anti-fracture and bone mineral density effects that persist for 3–5 years after an initial 3–5 years of treatment. [2] The bisphosphonate alendronate reduces the risk of hip, vertebral, and wrist fractures by 35-39%; zoledronate reduces the risk of hip fractures by 38% and of vertebral ...